Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Dystonia may be part of PAS-4 and linked to immune issues.

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Some alternative therapies for vitiligo show promise but need more research.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Vitamin D might help treat some types of hair loss, but more research is needed.

New treatments focusing on immune pathways show promise for stubborn hair loss.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Patients with Type 1 diabetes should be screened for pernicious anemia.